feed,title,long_url,short_url
Benzinga,Cellectis Reports Preliminary Results from its Phase 1 BALLI-01 Study of UCART22 in R/R Adult B-ALL at American Society of Hematology (ASH) Annual Meeting,https://www.benzinga.com/pressreleases/20/12/g18663829/cellectis-reports-preliminary-results-from-its-phase-1-balli-01-study-of-ucart22-in-rr-adult-b-all,https://j.mp/2VIjaOo
